Advertisement

Topics

Phil Erlanger Research Co., Inc. Company Profile

02:05 EST 17th December 2018 | BioPortfolio

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data, enabling Phil Erlanger Research to offer independent, value-added data and analysis on over 6000 equity issues, 139 industry groups and 18 sectors. Following his experience as Advest 's Chief Technical Analyst, and his 5 year tenure as Senior Technical Analyst for Fidelity Management & Research Co. , Inc., Philip B. Erlanger formed his own company with the goal of providing high quality, unique information and research.

Location

Maynard
Massachusetts
United States of America


News Articles [49 Associated News Articles listed on BioPortfolio]

Erlanger Health System partners with Viz.ai to transform stroke care

Erlanger Health System, a multi-hospital health system based in Tennessee have announced a partnership with Viz.ai., a leading applied artificial intelligence company, to transform stroke care.

Innovation’s Phil Samples elected to AMSUS board

Vertex Pharmaceuticals-Aktie bietet positives Profil!

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer Aktienanalys...

Vertex Pharmaceuticals-Aktie: Konkurrenz hat das Nachsehen!

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer Aktienanalys...

Viz.ai and Erlanger Health System Partner to Bring Innovative Artificial Intelligence to Stroke Care

Erlanger Health System, a multi-hospital health system based in Tennessee have announced a partnership with Viz.ai., a leading applied artificial intelligence company, to transfor...

Man flaunts incredible transformation after dropping 10 STONE in a year after a bet with co-worker – Scottish Daily Record

Scottish Daily RecordMan flaunts incredible transformation after dropping 10 STONE in a year after a bet with co-workerScottish Daily RecordPhil Hulton weighed a massive 25-stone at his worst, but man...

Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors

BOSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® te...

BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q3 2018 Results - Earnings Call Transcript

PubMed Articles [606 Associated PubMed Articles listed on BioPortfolio]

Treatment of post-traumatic joint contracture in a rabbit model using pulsed, high intensity laser and ultrasound.

Post-traumatic joint contracture induced by scar tissues following a surgery or injury can leave patients in a permanent state of pain and disability, which is difficult to resolve by current treatmen...

Increasing Residency Research Output While Cultivating Community Research Collaborations.

Having a research curriculum in addition to hosting a resident research day stimulates research activity in residency programs. Research collaborations outside an individual residency program may also...

Cultivating the Human Dimension in Research.

According to "Research Exemplars," research requires attending to matters of heart as much as mind. The human dimension in research-relationships, passion, resilience, and leadership-was the common th...

Development and validation of the Person-Centeredness of Research Scale.

Person-centeredness shifts the focus of healthcare and research to the needs and priorities of patients and communities, and may improve health outcomes. There are no instruments available, however, w...

Evaluation of a Center of Research Excellence in Polycystic Ovary Syndrome as a Large-Scale Collaborative Research Translation Initiative, Including Evaluating Translation of Guideline Impact.

Research translation and evaluation are often underconsidered in research design and implementation thus limiting research benefit to the end user. In this article, we first describe a best practice a...

Clinical Trials [1137 Associated Clinical Trials listed on BioPortfolio]

PHIL® Embolic System Pediatric IDE

The purpose of this study is to collect information about how the PHIL® Embolic System works in the treatment of intracranial dural arteriovenous fistulas. Data collected in this study wi...

PHIL in the Treatment of Intracranial dAVF.

This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualify...

PHIL Evaluation in the Endovascular Treatment of Intracranial Cerebral ArterioVenous Malformation (cAVM)

The primary objective of this study is to assess the efficacy and safety of PHIL® liquid embolic agent in endovascular embolization of cerebral arteriovenous malformations.

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF

The primary objective of this study is to demonstrate the safety and efficacy of the PHIL® liquid in endovascular treatment of dural arteriovenous fistula.

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian cancer may be caused by a build-up of genetic defects, or damaged genes within the cells of the body. Because the genes are damaged, the body is unable to produce a group of protei...

Companies [1060 Associated Companies listed on BioPortfolio]

Phil Erlanger Research Co., Inc.

Welcome to Erlanger.com, a resource for investors seeking advanced technical analysis research and data. State-of-the-art computational techniques are combined with important, proprietary market data,...

Purple Heart Injury Laboratories

PHIL is a Defense Medicine™ incubator that supports the development of new technologies and therapies for healing battlefield injuries. PHIL’s objective is to become the...

Phil Inc.

Phil is an end-to-end prescription management service providing a convenient alternative to traditional pharmaceutical management. Through its desktop website and mobile app, Phil...

Phil Ellis Associates, Inc.

Phil Ellis Associates, Inc. is a professional search and recruiting firm specializing in the pharmaceutical, medical device, diagnostic, biomedical and allied industries and operates under the guidanc...

ValueMedics Research, LLC

Jonothan C. Tierce, C.Phil., and Elisabeth H. Hazard, Ph.D., formed ValueMedics in 2003. The initial staff was made up of the Health Economics, Outcomes Research, Pricing and Market Access unit of the...

More Information about "Phil Erlanger Research Co., Inc." on BioPortfolio

We have published hundreds of Phil Erlanger Research Co., Inc. news stories on BioPortfolio along with dozens of Phil Erlanger Research Co., Inc. Clinical Trials and PubMed Articles about Phil Erlanger Research Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phil Erlanger Research Co., Inc. Companies in our database. You can also find out about relevant Phil Erlanger Research Co., Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record